FSD Pharma Valuation
| HUGE Stock | USD 0.46 0.03 6.12% |
FSD Pharma is overvalued. FSD Pharma Class shows a prevailing Real Value of $0.44 per share. The current price of the firm is $0.46. Our model computes the value of FSD Pharma Class from examining the firm fundamentals such as shares owned by insiders of 17.36 %, and Current Valuation of 15.22 M as well as evaluating its technical indicators and probability of bankruptcy. In general, most investors advise purchasing undervalued instruments and exiting overvalued instruments since, in the future, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting FSD Pharma's valuation include:
Price Book 1.8219 | Enterprise Value 15.2 M | Enterprise Value Ebitda (1.34) | Price Sales 105.0253 | Enterprise Value Revenue 119.6389 |
Overvalued
Today
Please note that FSD Pharma's price fluctuation is out of control at this time. Calculation of the real value of FSD Pharma Class is based on 3 months time horizon. Increasing FSD Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for FSD Pharma Class is useful when determining the fair value of the FSD stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of FSD Pharma. Since FSD Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of FSD Stock. However, FSD Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 0.44 | Hype 0.44 |
The real value of FSD Stock, also known as its intrinsic value, is the underlying worth of FSD Pharma Class Company, which is reflected in its stock price. It is based on FSD Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of FSD Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence FSD Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of FSD Pharma Class helps investors to forecast how FSD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of FSD Pharma more accurately as focusing exclusively on FSD Pharma's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use FSD Pharma's intrinsic value based on its ongoing forecasts of FSD Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against FSD Pharma's closest peers. When choosing an evaluation method for FSD Pharma Class, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
FSD Pharma Investments |
|
FSD Valuation Drivers Correlation
Many accounts on the financial statements of FSD Pharma Class are highly interrelated and sometimes correlated. Consequently, when conducting FSD's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of FSD
Click cells to compare fundamentals
FSD Valuation Trend
Knowing FSD Pharma's actual value is paramount for traders to make sound investment determinations. FSD Pharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of FSD Pharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both FSD Pharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
FSD Market Cap
FSD Pharma Class is one of the top stocks in market capitalization category among related companies. Market capitalization of Information Technology industry is currently estimated at about 85.8 Billion. FSD Pharma adds roughly 19.77 Million in market capitalization claiming only tiny portion of equities under Information Technology industry.FSD Pharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining FSD Pharma's current stock value. Our valuation model uses many indicators to compare FSD Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FSD Pharma competition to find correlations between indicators driving FSD Pharma's intrinsic value. More Info.FSD Pharma Class is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies . The current year's Price To Book Ratio is expected to grow to 2.90. Comparative valuation analysis is a catch-all model that can be used if you cannot value FSD Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for FSD Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FSD Pharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates FSD Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in FSD Pharma and how it compares across the competition.
About FSD Pharma Valuation
The stock valuation mechanism determines the current worth of FSD Pharma Class on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of FSD Pharma Class. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of FSD Pharma Class based exclusively on its fundamental and basic technical indicators. By analyzing FSD Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of FSD Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of FSD Pharma. We calculate exposure to FSD Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to FSD Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.6 M | -2.4 M | |
| Pretax Profit Margin | (232.65) | (244.29) | |
| Operating Profit Margin | (164.02) | (172.23) | |
| Net Loss | (234.03) | (245.73) | |
| Gross Profit Margin | (8.43) | (8.85) |
8 Steps to conduct FSD Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates FSD Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct FSD Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain FSD Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine FSD Pharma's revenue streams: Identify FSD Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research FSD Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish FSD Pharma's growth potential: Evaluate FSD Pharma's management, business model, and growth potential.
- Determine FSD Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate FSD Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
FSD Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as FSD Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 39.6 M |
FSD Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of FSD Pharma Class and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value FSD we look at many different elements of the entity such as FSD's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. FSD Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final FSD Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as FSD Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use FSD Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes FSD Pharma's worth.When determining whether FSD Pharma Class is a strong investment it is important to analyze FSD Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact FSD Pharma's future performance. For an informed investment choice regarding FSD Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in FSD Pharma Class. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.